As of 2025-10-15, the Relative Valuation of Denali Therapeutics Inc (DNLI) is (60.14) USD. This relative valuation is based on P/E multiples. With the latest stock price at 15.21 USD, the upside of Denali Therapeutics Inc based on Relative Valuation is -495.4%.
The range of the Relative Valuation is (49.68) - (63.32) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 15.9x - 21.9x | 18.9x |
| Forward P/E multiples | 17.2x - 28.2x | 22.7x |
| Fair Price | (49.68) - (63.32) | (60.14) |
| Upside | -426.6% - -516.3% | -495.4% |
| Date | P/E |
| 2025-10-15 | -5.55 |
| 2025-10-14 | -5.26 |
| 2025-10-13 | -5.18 |
| 2025-10-10 | -5.32 |
| 2025-10-09 | -5.59 |
| 2025-10-08 | -5.41 |
| 2025-10-07 | -5.15 |
| 2025-10-06 | -5.26 |
| 2025-10-03 | -5.33 |
| 2025-10-02 | -5.26 |
| 2025-10-01 | -5.16 |
| 2025-09-30 | -5.02 |
| 2025-09-29 | -5.02 |
| 2025-09-26 | -4.82 |
| 2025-09-25 | -4.64 |
| 2025-09-24 | -4.66 |
| 2025-09-23 | -4.51 |
| 2025-09-22 | -4.61 |
| 2025-09-19 | -4.41 |
| 2025-09-18 | -4.56 |
| 2025-09-17 | -4.52 |
| 2025-09-16 | -4.59 |
| 2025-09-15 | -4.55 |
| 2025-09-12 | -4.91 |
| 2025-09-11 | -5.13 |
| 2025-09-10 | -5.06 |
| 2025-09-09 | -5.31 |
| 2025-09-08 | -5.36 |
| 2025-09-05 | -5.34 |
| 2025-09-04 | -5.11 |
| 2025-09-03 | -5.29 |
| 2025-09-02 | -5.34 |
| 2025-08-29 | -5.28 |
| 2025-08-28 | -5.41 |
| 2025-08-27 | -5.40 |
| 2025-08-26 | -5.38 |
| 2025-08-25 | -5.38 |
| 2025-08-22 | -5.36 |
| 2025-08-21 | -5.27 |
| 2025-08-20 | -5.02 |
| 2025-08-19 | -5.12 |
| 2025-08-18 | -5.13 |
| 2025-08-15 | -5.08 |
| 2025-08-14 | -5.00 |
| 2025-08-13 | -5.12 |
| 2025-08-12 | -4.57 |
| 2025-08-11 | -4.81 |
| 2025-08-08 | -4.83 |
| 2025-08-07 | -4.92 |
| 2025-08-06 | -4.96 |